Lysine decarboxylase

From WikiMD's WELLNESSPEDIA

Lysine decarboxylase is an enzyme that catalyzes the decarboxylation of lysine to produce cadaverine, a process that is important in various biological systems. This enzyme is part of the group of decarboxylases, which are enzymes that remove a carboxyl group from amino acids, releasing carbon dioxide.

Function[edit]

Lysine decarboxylase plays a crucial role in the metabolism of lysine, an essential amino acid that must be obtained from the diet. The enzyme facilitates the conversion of lysine into cadaverine, a biogenic amine that is involved in cellular processes such as cell growth and differentiation.

Mechanism[edit]

The enzyme operates by binding to lysine and facilitating the removal of the carboxyl group, resulting in the formation of cadaverine and the release of carbon dioxide. This reaction is an example of a decarboxylation process, which is common in the metabolism of amino acids.

Biological Significance[edit]

Cadaverine, the product of the lysine decarboxylase reaction, is involved in various physiological processes. It is known to play a role in bacterial biofilm formation and can act as a signaling molecule in some organisms. In humans, cadaverine is found in small amounts and is associated with the breakdown of proteins during decomposition.

Clinical Relevance[edit]

Abnormal activity of lysine decarboxylase can be associated with certain medical conditions. For example, excessive production of cadaverine can lead to halitosis (bad breath) and other metabolic disorders. Understanding the regulation of this enzyme is important for developing treatments for such conditions.

Related Enzymes[edit]

Lysine decarboxylase is part of a larger family of decarboxylases that act on different amino acids. Other related enzymes include ornithine decarboxylase, which converts ornithine to putrescine, another biogenic amine.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.